News
Swissmedic approved the registration of IFINWIL (eflornithine) as a monotherapy to treat paediatric patients with high-risk neuroblastoma, ...
Chugai signed a joint research and licencing agreement with Singapore-based biotechnology firm Gero to create new antibody drug candidates ...
Several medical organisations have filed a lawsuit against RFK Jr and the HHS over recent changes to the US immunisation schedule.
The pulmonary arterial hypertension market is forecast to grow at a CAGR of 2.0% from 2024 to 2034, reaching $9.35bn across 7MM.
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Novartis’ Coartem (artemether-lumefantrine) Baby, described as the first malaria medicine for newborns and young infants. Known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results